NPPA issued a notification regarding the fixation of the retail price of Voglibose IP 0.3 mg+ Metformin Hydrochloride IP 500 mg (as sustained release) for M/s Pure and Cure Healthcare Pvt. Ltd (Manufacturer) & M/s Alkem Wellness Ltd. (Marketer)

Aug 16, 2026 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on August 11, 2026, issued a notification regarding the fixation of the retail price of Voglibose IP 0.3 mg+ Metformin Hydrochloride IP 500 mg (as sustained release) for M/s Pure and Cure Healthcare Pvt. Ltd (Manufacturer) & M/s Alkem Wellness Ltd. (Marketer).

It states that the price for each uncoated bilayered tablet containing Voglibose IP 0.3 mg+ Metformin Hydrochloride IP 500 mg has been fixed at Rs. 13.55/- excluding GST.

[Notification No. - 19(5278)/2026/DP/NPPA/Div.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT